Medikora vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 395,745 | 460,531 | 674,147 | 713,431 | 748,266 | 806,750 | 859,980 | 1,015,172 |
| Profit before tax | 2,821 | 21,924 | 95,024 | 18,898 | 3,379 | 7,680 | 7,096 | 10,298 |
| Net profit | 2,333 | 18,616 | 80,744 | 15,723 | 2,840 | 6,445 | 5,986 | 8,916 |
| Equity | 147,780 | 166,396 | 247,140 | 262,863 | 265,703 | 272,148 | 278,134 | 287,050 |
| Liabilities | 49,400 | 51,132 | 111,013 | 55,093 | 74,580 | 54,099 | 91,809 | 80,572 |
| Non-current assets | 20,877 | 9,570 | 56,420 | 50,829 | 43,095 | 31,941 | 41,927 | 27,806 |
| Current assets | 175,162 | 206,775 | 300,770 | 266,993 | 296,663 | 293,587 | 327,706 | 339,682 |
| Total assets | 196,039 | 216,345 | 357,190 | 317,822 | 339,758 | 325,528 | 369,633 | 367,488 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 35,649 | 37,593 | 49,689 |
| Social insurance contributions | - | - | - | - | - | 32,613 | 35,848 | 37,982 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +11.6% | +16.4% | +46.4% | +5.8% | +4.9% | +7.8% | +6.6% | +18.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.2% | 8.6% | 22.6% | 4.9% | 0.8% | 2.0% | 1.6% | 2.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.6% | 11.2% | 32.7% | 6.0% | 1.1% | 2.4% | 2.2% | 3.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.6% | 4.0% | 12.0% | 2.2% | 0.4% | 0.8% | 0.7% | 0.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.7% | 4.8% | 14.1% | 2.6% | 0.5% | 1.0% | 0.8% | 1.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.4 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 79,149 | 92,106 | 134,829 | 129,715 | 149,653 | 151,267 | 143,330 | 169,195 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medikora vaistinė - Social security debts
The company had no debts to Sodra
Medikora vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-30 | 2025-07-30 | 81.85 |
| 2025-07-28 | 2025-07-29 | 81.77 |
| 2025-02-20 | 2025-03-12 | 0.09 |
| 2025-02-19 | 2025-02-19 | 0.06 |
| 2025-02-13 | 2025-02-18 | 48.01 |
| 2025-02-02 | 2025-02-12 | 48.15 |
| 2025-01-30 | 2025-02-01 | 48.13 |
| 2025-01-29 | 2025-01-29 | 47.75 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medikora vaistine, UAB (code 166762194) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €1.02M, up 18.1% year on year and 25.8% over two years. Net profit increased to €8.9K in 2025 from €6.0K in 2024 and €6.4K in 2023, while profit margin remained low but stable at 0.9% in 2025, compared with 0.7% in 2024 and 0.8% in 2023. The balance sheet remained solid, with total assets of €367.5K, equity of €287.1K and liabilities of €80.6K at the end of 2025. Equity accounted for 78.1% of assets, and debt-to-equity stood at 0.28. Asset turnover was 2.76x, indicating efficient use of the asset base. Revenue per employee was €169.2K, while profit per employee was €1.5K. Overall, the company showed steady top-line growth and modest profitability across 2023-2025.